Polyphosphate-Functionalized Inorganic Nanoparticles for Rapid Hemostasis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing hemostatic compositions are inadequate for rapidly and effectively controlling severe bleeding, particularly in emergency situations where medical assistance is not immediately available, and there is a need for compositions that can initiate blood clotting quickly and safely without intensive training or equipment.
Innovation Solution
A hemostatic composition comprising nanoparticles functionalized with a polyphosphate polymer, which promotes blood clotting by activating the coagulation cascade, and can be administered as a medical device or intravenously, with a protecting agent that is enzymatically cleavable to ensure targeted activation at the hemorrhage site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If conventional hemostatic compositions are used, then blood clotting can be promoted, but the clotting time is too long and clot strength is insufficient for severe bleeding
Solution Approach 1:
The invention uses composite nanoparticles comprising a silica core coated with polyphosphate polymer and further functionalized with organic compounds. This multi-layer composite structure enables simultaneous activation of multiple coagulation pathways (contact pathway via polyphosphate and extrinsic pathway via organic compounds), achieving rapid clotting (reducing clotting time) while maintaining strong, stable clots under various physiological conditions
Solution Approach 2:
The nanoparticle surface is functionalized with different compounds at different layers: polyphosphate polymer at the interface with blood for contact pathway activation, and specific organic compounds (such as phospholipids or proteins) at the outer surface for extrinsic pathway activation. This spatial differentiation of functional qualities on the nanoparticle surface enables synergistic hemostatic effects
2Ease of operation
If hemostatic compositions are applied in emergency situations, then bleeding control is needed, but intensive training and equipment are required which are not available
Solution Approach 1:
The nanoparticle composition is designed to automatically activate both contact and extrinsic coagulation pathways upon contact with blood without requiring any additional activation steps, mixing, or specialized application techniques. The composition self-assembles and self-activates at the wound site, making it as easy to apply as conventional hemostatic agents while achieving superior and more reliable hemostatic effects
Solution Approach 2:
The nanoparticle composition serves multiple functions simultaneously: it activates contact pathway, activates extrinsic pathway, provides a scaffold for clot formation, and maintains stability under various physiological conditions (pH changes, temperature variations, hemodilution). This multi-functionality eliminates the need for multiple separate treatments or specialized equipment
3Productivity
If nanoparticles are functionalized with polyphosphate polymer, then coagulation cascade activation is enhanced, but the composition may lose stability
Solution Approach 1:
The polyphosphate polymer is pre-coated onto the silica nanoparticle surface during synthesis, forming a stable core-shell structure before any biological application. This preliminary functionalization ensures that the nanoparticles are preactivated and ready to immediately trigger coagulation upon blood contact, while the core-shell architecture maintains colloidal stability in storage and transport conditions
Solution Approach 2:
The silica core acts as an intermediary between the polyphosphate polymer and the biological environment. The polyphosphate layer is anchored to the silica surface through strong chemical bonds, preventing polymer degradation or aggregation, while the silica core provides structural integrity and colloidal stability. This intermediary structure allows the polyphosphate to remain stable yet biologically active
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly reduces clotting time and enhances clot strength, even under conditions of hemodilution, hypothermia, or acidosis, providing effective hemostasis in various bleeding scenarios.
Implementation Method 1
promotes blood clotting by activating the coagulation cascade
Implementation Method 2
a protecting agent that is enzymatically cleavable to ensure targeted activation at the hemorrhage site
Data Source
AI summary
A hemostatic composition is provided. The hemostatic composition includes a hemostatically effective amount of a hemostatic agent that includes a nanoparticle and a polyphosphate polymer attached to the nanoparticle. Also provided are medical devices and methods of use to promote blood clotting.